Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2021   $ 9 $ 282,266 $ (63) $ (173,627) $ (17) $ 108,568
Balance (in shares) at Jun. 30, 2021   8,715,000          
Shares issued 1,000            
Exercise of stock options     77       $ 77
Exercise of stock options (in shares)   3,000         3,380
Vesting of RSU's (in shares)   9,000          
Share-based compensation     4,377       $ 4,377
Warrant issued for Transaction     967       967
Acquisition of remaining portion of iBio CDMO     (68)     18 (50)
Unrealized gain (loss) on available-for-sale debt securities       (150)     (150)
Net loss         (50,303) $ (1) (50,304)
Balance at Jun. 30, 2022   $ 9 287,619 (213) (223,930)   63,485
Balance (in shares) at Jun. 30, 2022 1,000 8,727,000          
Capital raise   $ 11 12,316       12,327
Capital raise (in shares)   11,271,000          
Cost to raise capital     (636)       (636)
Asset Acquisition     650       $ 650
Asset Acquisition (in shares)   102,000          
Exercise of stock options (in shares)             0
Payment for fractional shares after reverse stock split     (39)       $ (39)
Payment for fractional shares after reverse stock split (in shares)   (8,000)          
Vesting of RSU's (in shares)   218,000          
Conversion of preferred stock to common stock (in shares) (1,000)            
Share-based compensation     4,391       4,391
Foreign currency translation adjustment       33     33
Reclassification adjustment for loss on available-for-sale debt securities realized in net income       21     21
Unrealized gain (loss) on available-for-sale debt securities       $ 159     159
Net loss         (65,010)   (65,010)
Balance at Jun. 30, 2023   $ 20 $ 304,301   $ (288,940)   $ 15,381
Balance (in shares) at Jun. 30, 2023   20,310,000